BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20235592)

  • 1. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
    Guimarães CR; Mathiowetz AM
    J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MM-GB/SA rescoring of docking poses in structure-based lead optimization.
    Guimarães CR; Cardozo M
    J Chem Inf Model; 2008 May; 48(5):958-70. PubMed ID: 18422307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the frozen atom approximation to the GB/SA continuum model for solvation free energy.
    Guvench O; Weiser J; Shenkin P; Kolossváry I; Still WC
    J Comput Chem; 2002 Jan; 23(2):214-21. PubMed ID: 11924735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprocessing of docked protein-ligand complexes using implicit solvation models.
    Lindström A; Edvinsson L; Johansson A; Andersson CD; Andersson IE; Raubacher F; Linusson A
    J Chem Inf Model; 2011 Feb; 51(2):267-82. PubMed ID: 21309544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
    Sham YY; Chu ZT; Tao H; Warshel A
    Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of protein-ligand binding free energy using smooth reaction path generation (SRPG) method: a comparison of the explicit water model, gb/sa model and docking score function.
    Mitomo D; Fukunishi Y; Higo J; Nakamura H
    Genome Inform; 2009 Oct; 23(1):85-97. PubMed ID: 20180264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches.
    Miyamoto S; Kollman PA
    Proteins; 1993 Jul; 16(3):226-45. PubMed ID: 8346190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-ligand binding affinity predictions by implicit solvent simulations: a tool for lead optimization?
    Michel J; Verdonk ML; Essex JW
    J Med Chem; 2006 Dec; 49(25):7427-39. PubMed ID: 17149872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of the binding affinities of PTP1B inhibitors with the MM-GB/SA method and the X-score scoring function.
    Zhang X; Li X; Wang R
    J Chem Inf Model; 2009 Apr; 49(4):1033-48. PubMed ID: 19320460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprocessing of protein-ligand docking poses using linear response MM-PB/SA: application to Wee1 kinase inhibitors.
    Wichapong K; Lawson M; Pianwanit S; Kokpol S; Sippl W
    J Chem Inf Model; 2010 Sep; 50(9):1574-88. PubMed ID: 20712342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines.
    Hylsová M; Carbain B; Fanfrlík J; Musilová L; Haldar S; Köprülüoğlu C; Ajani H; Brahmkshatriya PS; Jorda R; Kryštof V; Hobza P; Echalier A; Paruch K; Lepšík M
    Eur J Med Chem; 2017 Jan; 126():1118-1128. PubMed ID: 28039837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening to enrich a compound collection with CDK2 inhibitors using docking, scoring, and composite scoring models.
    Cotesta S; Giordanetto F; Trosset JY; Crivori P; Kroemer RT; Stouten PF; Vulpetti A
    Proteins; 2005 Sep; 60(4):629-43. PubMed ID: 16028223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to efficiently estimate solvation and explicit water energetics in ligand binding: the use of WaterMap.
    Yang Y; Lightstone FC; Wong SE
    Expert Opin Drug Discov; 2013 Mar; 8(3):277-87. PubMed ID: 23286874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Direct Comparison of the MM-GB/SA Scoring Procedure and Free-Energy Perturbation Calculations Using Carbonic Anhydrase as a Test Case: Strengths and Pitfalls of Each Approach.
    Guimarães CR
    J Chem Theory Comput; 2011 Jul; 7(7):2296-306. PubMed ID: 26606497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking.
    May A; Zacharias M
    J Med Chem; 2008 Jun; 51(12):3499-506. PubMed ID: 18517186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating protein-ligand binding free energy: atomic solvation parameters for partition coefficient and solvation free energy calculation.
    Pei J; Wang Q; Zhou J; Lai L
    Proteins; 2004 Dec; 57(4):651-64. PubMed ID: 15390269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test MM-PB/SA on true conformational ensembles of protein-ligand complexes.
    Li Y; Liu Z; Wang R
    J Chem Inf Model; 2010 Sep; 50(9):1682-92. PubMed ID: 20695488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-docking of inhibitors into CDK2 structures. 1.
    Duca JS; Madison VS; Voigt JH
    J Chem Inf Model; 2008 Mar; 48(3):659-68. PubMed ID: 18324799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid refinement of protein interfaces incorporating solvation: application to the docking problem.
    Jackson RM; Gabb HA; Sternberg MJ
    J Mol Biol; 1998 Feb; 276(1):265-85. PubMed ID: 9514726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.